Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab (TJ011133) With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

What's the purpose of this trial?

The purpose of this study is to assess how safe lemzoparlimab (TJ01133) is and how lemzoparlimab (TJ01133) moves through the body of adult participants with MM when given with or without dexamethasone, and in combination with other anti-myeloma regimens. Adverse events and change in disease activity will be assessed.

This is an upcoming trial that has not yet started accepting patients.

What will happen during the trial?

Additional Trial Information

Phase 1

Enrollment: 163 patients (estimated)

View More

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.


University of Arizona Comprehensive Cancer Center

Tucson, AZ

Not Yet Accepting


Moffitt Cancer Center Magnolia Campus

Tampa, FL

Not Yet Accepting


Norton Cancer Institute St. Matthews Campus

Louisville, KY

Not Yet Accepting


Tulane Cancer Center Tulane University School of Medicine

New Orleans, LA

Not Yet Accepting


Massachusetts General Hospital

Boston, MA

Not Yet Accepting


University of Michigan Comprehensive Cancer Center

Ann Arbor, MI

Not Yet Accepting

Henry Ford Hospital

Detroit, MI

Not Yet Accepting


Mayo Clinic (Rochester)

Rochester, MN

Not Yet Accepting

New Jersey

Rutgers Cancer Institute of New Jersey Rutgers, The State University of New Jersey

New Brunswick, NJ

Not Yet Accepting

New York

North Carolina

Wake Forest Baptist Comprehensive Cancer Center Wake Forest School of Medicine

Winston-Salem, NC

Not Yet Accepting

Duke Cancer Center Duke University Medical Center

Durham, NC

Not Yet Accepting


University of Pennsylvania Presbyterian Medical Center

Philadelphia, PA

Not Yet Accepting


Baylor Charles A. Sammons Cancer Center Baylor Scott & White Health

Dallas, TX

Not Yet Accepting


Huntsman Cancer Institute University of Utah

Salt Lake City, UT

Not Yet Accepting


UVA Cancer Center University of Virginia Health System

Charlottesville, VA

Not Yet Accepting


University of Washington School of Medicine

Seattle, WA

Not Yet Accepting


Aurora Sinai Medical Center

Milwaukee, WI

Not Yet Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message